A game changer....FDA approvalFrom the last CC:
''n regards to the FDA clearance, since the last call, we had a Q-Sub meeting with the FDA to discuss our proposed answers on last questions remaining. The Q-Sub meeting allows them to provide real-time feedback to the proposed answers. We are positive about our interactions with the FDA and expect to have final responses ready in the coming weeks. Upon our final submission of these responses, the FDA usually takes 60 days to respond, which would put a potential approval in the second half of calendar 2022 in line with our original expectations. While we await the FDA's clearance, we are advancing our commercial operations to ensure a successful commercial launch later this year.
This mean that just prior to the Q4 due november 23 in 4 months from now Opsen should have the FDA approval.
Thiis will make a ''Big SPLASH''on the share price and could be a 40 %
about what we has been seen in April with the Healt Canada OK.
The actual share price is trading in a new range .
Action: 'We have to be patient and a great reward for all share holders,
Later one OPSENS might be a take over target because of the potential it offer.